SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-003545
Filing Date
2018-02-27
Accepted
2018-02-27 17:10:49
Documents
4
Period of Report
2018-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K EMPLOYMENT AGREEMENTS acer-8k_20180222.htm 8-K 51139
2 EX-10.1 SCHELLING EMPLOYMENT AGREEMENT acer-ex101_8.htm EX-10.1 107379
3 EX-10.2 ANDREWS EMPLOYMENT AGREEMENT acer-ex102_6.htm EX-10.2 106870
4 EX-10.3 PALMIN EMPLOYMENT AGREEMENT acer-ex103_7.htm EX-10.3 107276
  Complete submission text file 0001564590-18-003545.txt   374231
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 18646293
SIC: 2834 Pharmaceutical Preparations